Drug intelligence / Profile preview

CBN-1000

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

CBN-1000 refers to a high-concentration cannabinol (CBN) product, typically formulated as an oil or tincture containing approximately 1,000 mg of cannabinol per bottle. Cannabinol is a minor cannabinoid found in Cannabis sativa and is structurally similar to THC but is non-intoxicating or only weakly psychoactive. It acts primarily as a weak agonist at the cannabinoid CB1 receptor and more potently at the CB2 receptor. Preclinical studies suggest that CBN may promote sleep by increasing both REM and non-REM sleep phases, with effects comparable to zolpidem in animal models. It also exhibits anti-inflammatory properties and may modulate pain via interaction with the endocannabinoid system. Recent research indicates potential for adjunctive use in estrogen receptor-positive breast cancer therapy when combined with exemestane, enhancing apoptosis and hormone modulation in preclinical models[6][10]. Commercially available formulations often include other cannabinoids such as CBD, CBC, or CBG for synergistic effects[7][9].

Brand names
CBN-1000CBN1000CBN 1000
Other names
1000mg CBN tincture1000mg cannabinol oil1000mg CBN-rich tincture
02

Targets

CYP1A1 (Cytochrome P450 1A1)CNR1 (Cannabinoid receptor 1)CES1 (Liver carboxylesterase 1)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)

Beyond the preview

Go deeper on CBN-1000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CBN-1000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call